DANBURY, Conn. — A biopharmaceutical company that specializes in diabetes treatments has appointed a new board chairman.
Biodel said that effective immediately, Brian Pereira, who has served on the drug maker's board since 2007, will become chairman. Current chairman Charles Sanders, who served as chairman since March 2010 after joining the board in August 2006, will continue to serve as a board member, Biodel said.
"I thank the board for their confidence in me as Biodel makes important steps forward in its development program," Pereira said. "I join the board in thanking Sanders for his guidance and leadership."